title: Aβ regulation-based multitarget strategy for drug discovery against Alzheimer's disease.
abstract: Alzheimer's disease (AD) is a progressively neurodegenerative disease that eventually leads to the irreversible loss of neurons and intellectual abilities, including cognition and memory. AD has become the most common cause of dementia in aged people, and the ill-defined pathogenesis of AD is seriously impeding the current drug discovery against this disease. To date, there is still a lack of etiologically therapeutic drugs for AD, although some symptomatic treatments have been successfully developed. The β-amyloid (Aβ)-induced neurodegeneration is determined as the main pathogenesis of AD, and by targeting the regulation of Aβ in production inhibition or clearance promotion, many active agents have been designed potentially for AD treatment, but no drug has yet been approved in clinical use. Actually, AD has a complex pathogenic mechanism that involves multiple aberrant signaling genes and pathways, and the idea of 'single target' for anti-AD drug research is thus full of challenges. Recently, with a deep understanding of AD pathogeneses and the development of advanced pharmacological techniques, 'multiple target'-based strategy has been widely applied for the drug discovery against this disease, and many promising results have been achieved. Here, we review the recent multitarget strategies for the drug discovery in the treatment of AD by focusing on the involvement of Aβ regulation.
authors.forename: Xiaodan
authors.initials: X
authors.lastname: Guo
authors.forename: Wei
authors.initials: W
authors.lastname: Jiang
authors.forename: Chenjing
authors.initials: C
authors.lastname: Li
authors.forename: Zhiyuan
authors.initials: Z
authors.lastname: Zhu
authors.forename: Xu
authors.initials: X
authors.lastname: Shen
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy* / Q000235:genetics; D016229:Amyloid beta-Peptides / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D000818:Animals; D055808:Drug Discovery / Q000379:methods*; D005786:Gene Expression Regulation; D006801:Humans; D024801:Tauopathies / Q000235:genetics / Q000378:metabolism; D016875:tau Proteins / Q000235:genetics / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D016875:tau Proteins